Cepheid
The Formulation Development Co-Op supports Cytiva’s preclinical Biopharma Services team in Vancouver by contributing to the design, optimization, and documentation of nanoparticle formulations for drug and nucleic acid delivery. This on-site co-op runs from May 4, 2026 to Dec 31, 2026 and focuses on hands-on laboratory work and method development.
Headquarters
Sunnyvale, California, United States
Company Size
5001-10000 employees
Founded
1996
Cepheid is delivering a better way to improve patient outcomes by enabling access to molecular diagnostic testing everywhere.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cepheid.
FDA Clears Rapid Multiplex GI Test That Could Transform Outbreak Detection and Infection Prevention
1 month ago
Scientist, Formulation Discovery
Eli Lilly and Company
Contract SRA / Scientist, Lipid Nanoparticle (LNP) Discovery
Addition Therapeutics
Associate Scientist/Scientist I, LNP Formulations
Flagship Pioneering, Inc.
Scientist, LNP Process and Development
Flagship Pioneering, Inc.
Research Associate/Senior Research Associate
Sail Biomedicines
Pharmaceutical Scientist (R2-R4)
Eli Lilly and Company